Drug Type Small molecule drug |
Synonyms 2-Carba cyclic phosphatidic acid |
Target |
Action agonists, inhibitors |
Mechanism LPAR agonists(Lysophosphatidic acid receptors agonists), autotaxin inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H41NaO5P |
InChIKeyLNGKSHJGHYPIQJ-KVVVOXFISA-N |
CAS Registry927880-40-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis, Knee | Phase 2 | Taiwan Province | 03 Nov 2022 | |
| Osteoarthritis | Preclinical | Japan | 14 Jun 2017 | |
| Osteoarthritis | Preclinical | Japan | 14 Jun 2017 | |
| Rheumatoid Arthritis | Preclinical | Japan | 14 Jun 2017 | |
| Rheumatoid Arthritis | Preclinical | Japan | 14 Jun 2017 |





